Want to see JP:7091 full AI Analyst Report?
Top Page
Living Platform Ltd.
(7091)
Select Model
Select Model
Rating:55Neutral
Price Target:
¥1,245.00
▲(17.67% Upside)
Action:Reiterated
Date:09/30/26
The score is driven primarily by improving operating performance but constrained by high leverage and inconsistent cash-flow conversion. Technically, the stock is trading below key moving averages with weak momentum, while valuation (reasonable P/E and dividend yield) provides partial support.
Positive Factors
Revenue Growth and EBIT Recovery
Revenue has grown strongly from 2021 to 2026, with the latest year up about 10%, while EBIT recovered from losses in 2023–2024 to solid profits in 2025–2026. This indicates improving operating traction and provides a stronger earnings base.
Negative Factors
High Financial Leverage
Debt remains high relative to equity, with debt-to-equity around 3.2x in 2025 and higher in earlier years. This debt-heavy structure can limit financial flexibility, increase the burden on operating cash flow, and make weaker earnings periods more difficult to manage.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth and EBIT Recovery
Revenue has grown strongly from 2021 to 2026, with the latest year up about 10%, while EBIT recovered from losses in 2023–2024 to solid profits in 2025–2026. This indicates improving operating traction and provides a stronger earnings base.
Read all positive factors
Living Platform Ltd. (7091) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.38B
Dividend Yield0.42%
Average Volume (3M)18.87K
Price to Earnings (P/E)11.1
Beta (1Y)0.23
Revenue Growth13.29%
EPS Growth17.57%
CountryJP
Employees1,326
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)107.62
Shares Outstanding4,484,742
10 Day Avg. Volume37,540
30 Day Avg. Volume18,866
Financial Highlights & Ratios
PEG Ratio1.78
Price to Book (P/B)2.22
Price to Sales (P/S)0.25
P/FCF Ratio16.39
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Living Platform Ltd. Business Overview & Revenue Model
Company Description
Established in 2011, Living Platform,Ltd. is a company based in Sapporo, Japan, that provides a range of services encompassing nursing care, childcare, and assistance for individuals with disabilities....
Living Platform Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
40
Negative
Cash Flow
54
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.65B | 22.06B | 19.20B | 16.66B | 13.69B | 11.63B |
| Gross Profit | 2.43B | 2.31B | 1.94B | 1.45B | 1.28B | 1.33B |
| EBITDA | 1.15B | 1.10B | 885.74M | 791.08M | 657.19M | 1.02B |
| Net Income | 482.33M | 396.83M | 365.59M | 189.35M | 91.70M | 407.96M |
Balance Sheet | ||||||
| Total Assets | 13.53B | 13.08B | 12.12B | 11.19B | 11.41B | 10.87B |
| Cash, Cash Equivalents and Short-Term Investments | 1.79B | 1.48B | 1.59B | 1.13B | 1.88B | 1.75B |
| Total Debt | 6.52B | 6.53B | 6.54B | 5.98B | 6.95B | 6.84B |
| Total Liabilities | 10.88B | 10.58B | 10.06B | 9.53B | 9.94B | 9.52B |
| Stockholders Equity | 2.65B | 2.49B | 2.05B | 1.66B | 1.47B | 1.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 337.55M | 81.26M | 881.05M | -729.95M | -638.06M |
| Operating Cash Flow | 0.00 | 871.51M | 612.28M | 1.51B | 93.00M | 443.61M |
| Investing Cash Flow | 0.00 | -989.72M | -722.06M | -1.26B | -15.55M | -498.01M |
| Financing Cash Flow | 0.00 | 3.47M | 574.58M | -1.00B | 53.24M | 217.58M |
Living Platform Ltd. Technical Analysis
Negative
1058.00
Price Trends
1246.88
Negative
1228.55
Negative
1202.37
Negative
Market Momentum
-2.82
Positive
37.39
Neutral
1.21
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7091, the sentiment is Negative. The current price of 1058 is below the 20-day moving average (MA) of 1269.00, below the 50-day MA of 1246.88, and below the 200-day MA of 1202.37, indicating a bearish trend. The MACD of -2.82 indicates Positive momentum. The RSI at 37.39 is Neutral, neither overbought nor oversold. The STOCH value of 1.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7091.
Living Platform Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥3.19B | 7.27 | ― | 3.26% | 5.48% | 13.46% | |
64 Neutral | ¥2.31B | 4.77 | ― | 3.90% | 2.01% | 2.55% | |
56 Neutral | ¥6.03B | 20.80 | ― | 3.83% | 4.76% | -52.55% | |
56 Neutral | ¥2.57B | 31.12 | ― | 3.18% | -5.72% | -73.78% | |
55 Neutral | ¥5.38B | 11.11 | ― | 0.42% | 13.29% | 17.57% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:7091
Living Platform Ltd.
1,196.00
268.91
29.01%
JP:2373
Care Twentyone Corporation
442.00
12.63
2.94%
JP:2425
Care Service Co., Ltd.
692.00
-85.66
-11.02%
JP:2435
Cedar. Co.,Ltd
205.00
0.41
0.20%
JP:9220
FB CARE SERVICE CO.,LTD.
1,319.00
150.03
12.83%
Living Platform Ltd. Corporate Events
Living Platform Profit Surges on Rising Occupancy and Record Quarterly Sales
Aug 14, 2026
Living Platform, Ltd. reported that occupancy rates continued to improve in the first quarter of FY2027.3, underscoring stronger demand for its residential services and more efficient use of its facility portfolio.Supported by higher occupancy, th...
Living Platform Delivers Strong Quarterly Profit Growth and Confirms Dividend Outlook
Aug 14, 2026
Living Platform reported revenue of ¥5.95 billion for the quarter ended June 30, 2026, up 11.1% year on year, with operating profit surging 79.6% to ¥216 million and profit attributable to owners of parent climbing 87.2% to ¥174 mil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.